Santarus Announces Development Program For New ZEGERID Prescription Product
Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, announced that it is developing a new tablet formulation to add to its ZEGERID family of branded prescription pharmaceutical products. The new formulation is a swallowable tablet that combines immediate-release omeprazole, a proton pump inhibitor (PPI), with a mix of buffers.
Osteologix Presents Phase 2 Osteoporosis Data At A Major European Medical Conference
Osteologix, Inc. (OTCBB: OLGX), a specialty pharmaceutical company, announced today that data from a Phase II clinical study of NB S101 (strontium malonate) was presented at the European Calcified Tissue Society's 35th Annual Meeting in Barcelona, Spain.
Neose Announces Two Abstracts On GlycoPEGylated Factor VIIa Accepted For Presentation At The Hemophilia 2008 World Congress
Neose Technologies, Inc.
Stars From Film, Television, Sports, Journalism And Music Come Together For Sept. 5 Prime Time Television Event To Raise Funds For Cancer Research
Stand Up To Cancer (http://www.standup2cancer.org/), a new initiative to raise philanthropic dollars for accelerating ground-breaking research, launches through an unprecedented collaboration uniting the major television networks, entertainment industry executives, celebrities and prominent leaders in cancer research and patient advocacy.
AVANIR Announces Positive Outcome Of Zenvia PK Study
AVANIR Pharmaceuticals (NASDAQ:AVNR) reported a positive outcome of its large, formal pharmacokinetic (PK) study of its investigational drug Zenvia™ (dextromethorphan/quinidine [DM/Q]).
AACE Launches Website To Promote Patient Safety
The American Association of Clinical Endocrinologists (AACE) announced the launch of a one-of-a-kind resource for patients and their healthcare professionals at its 17th Annual Meeting and Clinical Congress in Orlando, FL. The website, called the Patient Safety Exchange, is now live and free for anyone to use.
Age And Ethnicity Of Patients Influence Development Of Cardiovascular Drug Therapies
The rising prevalence of cardiovascular conditions such as stroke, heart failure and coronary artery disease (CAD) hastens the development of suitable cardiovascular drug therapies among the elderly.
LDR Announces Release Of Its ROI-T TM Transforaminal Approach Implant
LDR, a total spine solution company, announced that it has begun to market its ROI-T™ partial vertebral body replacement device following recent 510(k) clearance from the United States Food and Drug Administration.
Infosys Technologies Transforms Healthcare Management Program, Improving Access For Underserved Communities
Infosys Technologies Limited (NASDAQ:INFY) announced that it has completed deployment of a patient management tool for an award-winning health information technology (IT) initiative to improve healthcare access for rural and underserved patients.
Study Presented At SpineWeek Finds Plasma Disc Decompression Effective For Contained Cervical Disc Herniation
ArthroCare Corp. (Nasdaq: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced that a study demonstrating the effectiveness of plasma disc decompression (PDD) for treating patients with contained disc herniation was presented from the podium yesterday at SpineWeek 2008 in Geneva.